CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 29, 2015-- Seres Therapeutics Inc. (Nasdaq: MCRB), a leading microbiome therapeutics platform company, today announced its participation in two upcoming investor conferences in November:

• Citi 2015 Global Healthcare Conference in New York City on Wednesday, November 4, 2015. Seres’ management will participate in one-to-one and small-group meetings.
• Credit Suisse 24^th Annual Healthcare Conference in Scottsdale, Ariz., on Wednesday, November 11, 2015, at 2 p.m. MST. Management will present a corporate overview.

A live audio webcast of the presentation will be available under the “Investors and Media” section of Seres’ website at www.serestherapeutics.com. A replay of the presentation will become available approximately one hour after the event and will be archived on the site.

About Seres Therapeutics

Seres Therapeutics Inc. is a leading microbiome therapeutics platform company developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151029005257/en/

Source: Seres Therapeutics Inc.

IR Contact:
Stern Investor Relations Inc.
Beth DelGiacco, 212-362-1200
Beth@sternir.com
or
PR Contact:
Ten Bridge Communications Inc.
Dan Quinn, 781-475-7974
Dan@tenbridgecommunications.com